Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients

G. Ponti, G. Pellacani, C. Ruini, A. Percesepe, C. Longo, V. Desmond Mandel, F. Crucianelli, G. Gorelli, A. Tomasi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Primary and secondary immunodepressive conditions are associated with an increased incidence of sebaceous tumors. Microsatellite instability (MSI) and lack of expression of mismatch repair (MMR) proteins, typical markers of Muir–Torre/Lynch heredo-familial settings, can be recognized also in immunocompromised patients. We aimed to carry on a systematic examination of clinical, immunohistochemical, biomolecular features of sebaceous tumors arising in immunocompromised and immunocompetent patients between 1986 and 2012. Microsatellite screening, immunohistochemical analysis and genetic testing were performed for hMLH1, hMSH2 and hMSH6. Methylation status of MMR genes was checked in cases with immunohistochemistry (IHC) loss of MMR proteins expression and no germline mutations. Fifteen patients had a personal history of visceral carcinomas fulfilling diagnostic criteria for Muir–Torre syndrome. In this cohort, IHC analysis, MSI status and genetic testing were in agreement, showing eight MSH2 and two MLH1 germline mutations. Five patients were immunosuppressed and their sebaceous tumors showed a lack of MSH2/MSH6 expression, although just one case with positive family history for visceral cancer harbored a germline mutation. In immunosuppressed patients, loss of IHC for MMR proteins is not necessarily secondary to MMR germline mutations. IHC false positives are probably due to epigenetic alterations. MSI and lack of expression of MMR proteins can be recognized also in immunocompromised patients without MMR germline mutations.

Original languageEnglish
Pages (from-to)553-561
Number of pages9
JournalFamilial Cancer
Volume13
Issue number4
DOIs
Publication statusPublished - Jun 27 2014

Fingerprint

DNA Mismatch Repair
Immunocompromised Host
Germ-Line Mutation
Microsatellite Instability
Immunohistochemistry
Neoplasms
Proteins
Genetic Testing
Epigenomics
Microsatellite Repeats
Methylation
Cohort Studies
Carcinoma
Incidence
Genes

Keywords

  • Immunodepression
  • Mismatch repair genes
  • Mismatch repair proteins
  • MMR proteins immunohistochemical expression
  • Muir–Torre syndrome
  • Sebaceous tumors

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Oncology
  • Genetics(clinical)
  • Medicine(all)

Cite this

Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients. / Ponti, G.; Pellacani, G.; Ruini, C.; Percesepe, A.; Longo, C.; Mandel, V. Desmond; Crucianelli, F.; Gorelli, G.; Tomasi, A.

In: Familial Cancer, Vol. 13, No. 4, 27.06.2014, p. 553-561.

Research output: Contribution to journalArticle

Ponti, G. ; Pellacani, G. ; Ruini, C. ; Percesepe, A. ; Longo, C. ; Mandel, V. Desmond ; Crucianelli, F. ; Gorelli, G. ; Tomasi, A. / Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients. In: Familial Cancer. 2014 ; Vol. 13, No. 4. pp. 553-561.
@article{f19b2811bc7846b284878736bf7365a0,
title = "Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients",
abstract = "Primary and secondary immunodepressive conditions are associated with an increased incidence of sebaceous tumors. Microsatellite instability (MSI) and lack of expression of mismatch repair (MMR) proteins, typical markers of Muir–Torre/Lynch heredo-familial settings, can be recognized also in immunocompromised patients. We aimed to carry on a systematic examination of clinical, immunohistochemical, biomolecular features of sebaceous tumors arising in immunocompromised and immunocompetent patients between 1986 and 2012. Microsatellite screening, immunohistochemical analysis and genetic testing were performed for hMLH1, hMSH2 and hMSH6. Methylation status of MMR genes was checked in cases with immunohistochemistry (IHC) loss of MMR proteins expression and no germline mutations. Fifteen patients had a personal history of visceral carcinomas fulfilling diagnostic criteria for Muir–Torre syndrome. In this cohort, IHC analysis, MSI status and genetic testing were in agreement, showing eight MSH2 and two MLH1 germline mutations. Five patients were immunosuppressed and their sebaceous tumors showed a lack of MSH2/MSH6 expression, although just one case with positive family history for visceral cancer harbored a germline mutation. In immunosuppressed patients, loss of IHC for MMR proteins is not necessarily secondary to MMR germline mutations. IHC false positives are probably due to epigenetic alterations. MSI and lack of expression of MMR proteins can be recognized also in immunocompromised patients without MMR germline mutations.",
keywords = "Immunodepression, Mismatch repair genes, Mismatch repair proteins, MMR proteins immunohistochemical expression, Muir–Torre syndrome, Sebaceous tumors",
author = "G. Ponti and G. Pellacani and C. Ruini and A. Percesepe and C. Longo and Mandel, {V. Desmond} and F. Crucianelli and G. Gorelli and A. Tomasi",
year = "2014",
month = "6",
day = "27",
doi = "10.1007/s10689-014-9733-4",
language = "English",
volume = "13",
pages = "553--561",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients

AU - Ponti, G.

AU - Pellacani, G.

AU - Ruini, C.

AU - Percesepe, A.

AU - Longo, C.

AU - Mandel, V. Desmond

AU - Crucianelli, F.

AU - Gorelli, G.

AU - Tomasi, A.

PY - 2014/6/27

Y1 - 2014/6/27

N2 - Primary and secondary immunodepressive conditions are associated with an increased incidence of sebaceous tumors. Microsatellite instability (MSI) and lack of expression of mismatch repair (MMR) proteins, typical markers of Muir–Torre/Lynch heredo-familial settings, can be recognized also in immunocompromised patients. We aimed to carry on a systematic examination of clinical, immunohistochemical, biomolecular features of sebaceous tumors arising in immunocompromised and immunocompetent patients between 1986 and 2012. Microsatellite screening, immunohistochemical analysis and genetic testing were performed for hMLH1, hMSH2 and hMSH6. Methylation status of MMR genes was checked in cases with immunohistochemistry (IHC) loss of MMR proteins expression and no germline mutations. Fifteen patients had a personal history of visceral carcinomas fulfilling diagnostic criteria for Muir–Torre syndrome. In this cohort, IHC analysis, MSI status and genetic testing were in agreement, showing eight MSH2 and two MLH1 germline mutations. Five patients were immunosuppressed and their sebaceous tumors showed a lack of MSH2/MSH6 expression, although just one case with positive family history for visceral cancer harbored a germline mutation. In immunosuppressed patients, loss of IHC for MMR proteins is not necessarily secondary to MMR germline mutations. IHC false positives are probably due to epigenetic alterations. MSI and lack of expression of MMR proteins can be recognized also in immunocompromised patients without MMR germline mutations.

AB - Primary and secondary immunodepressive conditions are associated with an increased incidence of sebaceous tumors. Microsatellite instability (MSI) and lack of expression of mismatch repair (MMR) proteins, typical markers of Muir–Torre/Lynch heredo-familial settings, can be recognized also in immunocompromised patients. We aimed to carry on a systematic examination of clinical, immunohistochemical, biomolecular features of sebaceous tumors arising in immunocompromised and immunocompetent patients between 1986 and 2012. Microsatellite screening, immunohistochemical analysis and genetic testing were performed for hMLH1, hMSH2 and hMSH6. Methylation status of MMR genes was checked in cases with immunohistochemistry (IHC) loss of MMR proteins expression and no germline mutations. Fifteen patients had a personal history of visceral carcinomas fulfilling diagnostic criteria for Muir–Torre syndrome. In this cohort, IHC analysis, MSI status and genetic testing were in agreement, showing eight MSH2 and two MLH1 germline mutations. Five patients were immunosuppressed and their sebaceous tumors showed a lack of MSH2/MSH6 expression, although just one case with positive family history for visceral cancer harbored a germline mutation. In immunosuppressed patients, loss of IHC for MMR proteins is not necessarily secondary to MMR germline mutations. IHC false positives are probably due to epigenetic alterations. MSI and lack of expression of MMR proteins can be recognized also in immunocompromised patients without MMR germline mutations.

KW - Immunodepression

KW - Mismatch repair genes

KW - Mismatch repair proteins

KW - MMR proteins immunohistochemical expression

KW - Muir–Torre syndrome

KW - Sebaceous tumors

UR - http://www.scopus.com/inward/record.url?scp=84937512142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937512142&partnerID=8YFLogxK

U2 - 10.1007/s10689-014-9733-4

DO - 10.1007/s10689-014-9733-4

M3 - Article

C2 - 24969397

AN - SCOPUS:84937512142

VL - 13

SP - 553

EP - 561

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 4

ER -